123 related articles for article (PubMed ID: 37608419)
1. [A Case of Advanced Esophagogastric Junction Adenocarcinoma with Enlarged Lymph Node Metastases of the Middle Mediastinum and Intraperitoneal That Exhibited pCR by Preoperative SOX Therapy].
Mita K; Oda H; Sato M; Takahashi K; Shimaguchi M; Kobayashi N; Kouno M; Toyota T; Toyota N; Hatano M; Sasaki J; Kawamura Y; Nishida K
Gan To Kagaku Ryoho; 2023 Aug; 50(8):909-912. PubMed ID: 37608419
[TBL] [Abstract][Full Text] [Related]
2. [A Case of cStage Ⅲ Esophagogastric Junction Adenocarcinoma That Showed pCR to Preoperative Chemotherapy Containing SOX].
Kobayashi T; Kosuga T; Kubota T; Okamoto K; Shoda K; Konishi H; Shiozaki A; Fujiwara H; Arita T; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Otsuji E
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2369-2371. PubMed ID: 30692467
[TBL] [Abstract][Full Text] [Related]
3. [A Case of Advanced Adenocarcinoma at the Esophagogastric Junction That Exhibited pCR by Preoperative SOX Therapy].
Mihara D; Kuwada K; Hamazaki T; Namba K; Takahashi T; Takehara K; Kuise T; Kuroda M; Yamano T; Takagi S; Ikeda E; Kemmotsu M; Ikeda T
Gan To Kagaku Ryoho; 2022 Jun; 49(6):693-696. PubMed ID: 35799398
[TBL] [Abstract][Full Text] [Related]
4. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
Mine S; Watanabe M; Kumagai K; Okamura A; Yuda M; Hayami M; Yamashita K; Imamura Y; Ishizuka N
Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30791046
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival following radical surgery after chemotherapy for esophagogastric adenocarcinoma with extensive lymph node metastases: report of a case.
Aoki Y; Toh Y; Taomoto J; Sakaguchi Y; Okamura T
Surg Today; 2011 Sep; 41(9):1255-9. PubMed ID: 21874426
[TBL] [Abstract][Full Text] [Related]
6. Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT.
Liu X; Jin J; Cai H; Huang H; Zhao G; Zhou Y; Wu J; Du C; Long Z; Fang Y; Ma M; Li G; Zhou M; Yin J; Zhu X; Zhu J; Sheng W; Huang D; Zhu H; Zhang Z; Lu Q; Xie L; Zhang Z; Wang Y
BMC Cancer; 2019 Jun; 19(1):606. PubMed ID: 31221115
[TBL] [Abstract][Full Text] [Related]
7. [Thoracoscopic laparoscopy-assisted Ivor-Lewis resection of esophagogastric junction cancer].
Zhang XF; Wang Z; Liu WX; Li F; He J; Zhang F; Zhang MY; Qi L; Li Y
Zhonghua Zhong Liu Za Zhi; 2023 Apr; 45(4):368-374. PubMed ID: 37078219
[No Abstract] [Full Text] [Related]
8. [A Case of Advanced Esophagogastric Junction Cancer Responding to S-1 Neoadjuvant Chemotherapy].
Kuroda J; Aoki H; Kondou N; Sumita T; Itoh K; Agawa S
Gan To Kagaku Ryoho; 2018 Apr; 45(4):688-690. PubMed ID: 29650836
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Successful Multidisciplinary Therapy for Advanced Esophagogastric Junction Cancer with Multiple Lymph Node Metastase].
Murakami K; Tamura S; Takeno A; Ishida T; Kuwahara R; Akiyama Y; Sakamoto T; Inatome J; Naito A; Katsura Y; Ohmura Y; Kagawa Y; Egawa C; Takeda Y; Kato T
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2010-2012. PubMed ID: 28133205
[TBL] [Abstract][Full Text] [Related]
10. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
11. Optimal surgical management for esophagogastric junction carcinoma.
Matsuda T; Takeuchi H; Tsuwano S; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
Gen Thorac Cardiovasc Surg; 2014 Sep; 62(9):560-6. PubMed ID: 24570201
[TBL] [Abstract][Full Text] [Related]
12. A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301 (Trigger Study).
Kataoka K; Tokunaga M; Mizusawa J; Machida N; Katayama H; Shitara K; Tomita T; Nakamura K; Boku N; Sano T; Terashima M; Sasako M;
Jpn J Clin Oncol; 2015 Nov; 45(11):1082-6. PubMed ID: 26355164
[TBL] [Abstract][Full Text] [Related]
13. [Pathological Complete Response in a Case of Advanced Esophageal Cancer with Widespread Lymph Node Metastases Treated Using Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-FU(DCF therapy)].
Noro H; Hirao T; Takaichi S; Son C; Iwamoto K; Kono E; Yasumasa K; Mizuno H; Morimoto Y; Hatanaka N; Yamasaki Y
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2178-2180. PubMed ID: 28133261
[TBL] [Abstract][Full Text] [Related]
14. The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction.
Dresner SM; Lamb PJ; Bennett MK; Hayes N; Griffin SM
Surgery; 2001 Jan; 129(1):103-9. PubMed ID: 11150040
[TBL] [Abstract][Full Text] [Related]
15. [A case of HER2-positive esophagogastric junction cancer treated by using a neoadjuvant chemotherapy regimen consisting of trastuzumab].
Kanaya N; Arata T; Tanakaya K; Yamasaki R; Aoki H; Takeuchi H
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2285-6. PubMed ID: 25731497
[TBL] [Abstract][Full Text] [Related]
16. [Understanding of the lower mediastinal lymph node dissection in the adenocarcinoma of the esophagogastric junction through abdomino-transhiatal approach].
Hu WQ; Cui P; Zhang JJ; Zhao ZQ; Xu JW; Liu XM; Wang J; Niu RL; Liu Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Oct; 22(10):932-936. PubMed ID: 31630489
[TBL] [Abstract][Full Text] [Related]
17. [Subtotal Esophagectomy for Mediastinal Lymph Node Oligo-Recurrence of ALK-Positive Lung Adenocarcinoma - A Case Report].
Tetsumoto S; Okada K; Nagata H; Toyota S; Tanaka S; Niki T; Tsuruta N; Higaki N; Niju T; Oka Y; Nezu R; Ikeda T
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1452-1454. PubMed ID: 29394665
[TBL] [Abstract][Full Text] [Related]
18. [A Case of Esophago-Gastric Junctional Carcinoma with Intramural Invasion and Cervical Lymph Node Metastasis].
Hiramoto H; Konishi H; Shiozaki A; Fujiwara H; Arita T; Kosuga T; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Okamoto K; Otsuji E
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1677-1679. PubMed ID: 29394740
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of the Location of Lymph Node Metastases in Patients With Adenocarcinoma of the Distal Esophagus or Gastroesophageal Junction.
Anderegg MC; Lagarde SM; Jagadesham VP; Gisbertz SS; Immanuel A; Meijer SL; Hulshof MC; Bergman JJ; van Laarhoven HW; Griffin SM; van Berge Henegouwen MI
Ann Surg; 2016 Nov; 264(5):847-853. PubMed ID: 27429034
[TBL] [Abstract][Full Text] [Related]
20. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
Gu Y; Swisher SG; Ajani JA; Correa AM; Hofstetter WL; Liao Z; Komaki RR; Rashid A; Hamilton SR; Wu TT
Cancer; 2006 Mar; 106(5):1017-25. PubMed ID: 16456809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
